Cargando…

Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study

PURPOSE: Although comorbidities, frailty, and functional impairment are common in older adults (OA) with cancer, little is known about how these factors are considered during the treatment decision-making process by OAs, their families, and health care providers. Our aim was to better understand the...

Descripción completa

Detalles Bibliográficos
Autores principales: Puts, Martine T. E., Sattar, Schroder, McWatters, Kara, Lee, Katherine, Kulik, Michael, MacDonald, Mary-Ellen, Jang, Raymond, Amir, Eitan, Krzyzanowska, Monika K., Leighl, Natasha, Fitch, Margaret, Joshua, Anthony M., Warde, Padraig, Tourangeau, Ann E., Alibhai, Shabbir M. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266767/
https://www.ncbi.nlm.nih.gov/pubmed/27830393
http://dx.doi.org/10.1007/s00520-016-3476-8
_version_ 1782500508954525696
author Puts, Martine T. E.
Sattar, Schroder
McWatters, Kara
Lee, Katherine
Kulik, Michael
MacDonald, Mary-Ellen
Jang, Raymond
Amir, Eitan
Krzyzanowska, Monika K.
Leighl, Natasha
Fitch, Margaret
Joshua, Anthony M.
Warde, Padraig
Tourangeau, Ann E.
Alibhai, Shabbir M. H.
author_facet Puts, Martine T. E.
Sattar, Schroder
McWatters, Kara
Lee, Katherine
Kulik, Michael
MacDonald, Mary-Ellen
Jang, Raymond
Amir, Eitan
Krzyzanowska, Monika K.
Leighl, Natasha
Fitch, Margaret
Joshua, Anthony M.
Warde, Padraig
Tourangeau, Ann E.
Alibhai, Shabbir M. H.
author_sort Puts, Martine T. E.
collection PubMed
description PURPOSE: Although comorbidities, frailty, and functional impairment are common in older adults (OA) with cancer, little is known about how these factors are considered during the treatment decision-making process by OAs, their families, and health care providers. Our aim was to better understand the treatment decision process from all these perspectives. METHODS: A mixed methods multi-perspective longitudinal study using semi-structured interviews and surveys with 29 OAs aged ≥70 years with advanced prostate, breast, colorectal, or lung cancer, 24 of their family members,13 oncologists, and 15 family physicians was conducted. The sample was stratified on age (70–79 and 80+). All interviews were analyzed using thematic analysis. RESULTS: There was no difference in the treatment decision-making experience based on age. Most OAs felt that they should have the final say in the treatment decision, but strongly valued their oncologists’ opinion. “Trust in my oncologist” and “chemotherapy as the last resort to prolong life” were the most important reasons to accept treatment. Families indicated a need to improve communication between them, the patient and the specialist, particularly around goals of treatment. Comorbidity and potential side-effects did not play a major role in the treatment decision-making for patients, families, or oncologists. Family physicians reported no involvement in decisions but desired to be more involved. CONCLUSION: This first study using multiple perspectives showed neither frailty nor comorbidity played a role in the treatment decision-making process. Efforts to improve communication were identified as an opportunity that may enhance quality of care. CONDENSED ABSTRACT: In a mixed methods study multiple perspective study with older adults with cancer, their family members, their oncologist and their family physician we explored the treatment decision making process and found that most older adults were satisfied with their decision. Comorbidity, functional status and frailty did not impact the older adult’s or their family members’ decision. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00520-016-3476-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5266767
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-52667672017-02-09 Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study Puts, Martine T. E. Sattar, Schroder McWatters, Kara Lee, Katherine Kulik, Michael MacDonald, Mary-Ellen Jang, Raymond Amir, Eitan Krzyzanowska, Monika K. Leighl, Natasha Fitch, Margaret Joshua, Anthony M. Warde, Padraig Tourangeau, Ann E. Alibhai, Shabbir M. H. Support Care Cancer Original Article PURPOSE: Although comorbidities, frailty, and functional impairment are common in older adults (OA) with cancer, little is known about how these factors are considered during the treatment decision-making process by OAs, their families, and health care providers. Our aim was to better understand the treatment decision process from all these perspectives. METHODS: A mixed methods multi-perspective longitudinal study using semi-structured interviews and surveys with 29 OAs aged ≥70 years with advanced prostate, breast, colorectal, or lung cancer, 24 of their family members,13 oncologists, and 15 family physicians was conducted. The sample was stratified on age (70–79 and 80+). All interviews were analyzed using thematic analysis. RESULTS: There was no difference in the treatment decision-making experience based on age. Most OAs felt that they should have the final say in the treatment decision, but strongly valued their oncologists’ opinion. “Trust in my oncologist” and “chemotherapy as the last resort to prolong life” were the most important reasons to accept treatment. Families indicated a need to improve communication between them, the patient and the specialist, particularly around goals of treatment. Comorbidity and potential side-effects did not play a major role in the treatment decision-making for patients, families, or oncologists. Family physicians reported no involvement in decisions but desired to be more involved. CONCLUSION: This first study using multiple perspectives showed neither frailty nor comorbidity played a role in the treatment decision-making process. Efforts to improve communication were identified as an opportunity that may enhance quality of care. CONDENSED ABSTRACT: In a mixed methods study multiple perspective study with older adults with cancer, their family members, their oncologist and their family physician we explored the treatment decision making process and found that most older adults were satisfied with their decision. Comorbidity, functional status and frailty did not impact the older adult’s or their family members’ decision. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00520-016-3476-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-11-09 2017 /pmc/articles/PMC5266767/ /pubmed/27830393 http://dx.doi.org/10.1007/s00520-016-3476-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Puts, Martine T. E.
Sattar, Schroder
McWatters, Kara
Lee, Katherine
Kulik, Michael
MacDonald, Mary-Ellen
Jang, Raymond
Amir, Eitan
Krzyzanowska, Monika K.
Leighl, Natasha
Fitch, Margaret
Joshua, Anthony M.
Warde, Padraig
Tourangeau, Ann E.
Alibhai, Shabbir M. H.
Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title_full Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title_fullStr Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title_full_unstemmed Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title_short Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
title_sort chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266767/
https://www.ncbi.nlm.nih.gov/pubmed/27830393
http://dx.doi.org/10.1007/s00520-016-3476-8
work_keys_str_mv AT putsmartinete chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT sattarschroder chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT mcwatterskara chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT leekatherine chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT kulikmichael chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT macdonaldmaryellen chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT jangraymond chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT amireitan chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT krzyzanowskamonikak chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT leighlnatasha chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT fitchmargaret chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT joshuaanthonym chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT wardepadraig chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT tourangeauanne chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy
AT alibhaishabbirmh chemotherapytreatmentdecisionmakingexperiencesofolderadultswithcancertheirfamilymembersoncologistsandfamilyphysiciansamixedmethodsstudy